*Pseudomonas aeruginosa* is a Gram-negative bacterial pathogen commonly associated with the cystic fibrosis (CF) lung. Upon infection, a switch occurs between two contrasting modes of bacterial growth. Acute infection is characterised by a planktonic lifestyle whereby *P. aeruginosa* is motile and induces the type III secretion system (T3SS). The transition to chronic infection coincides with a *P. aeruginosa* behavioural switch to a sessile lifestyle, evident by the loss of motility, a shift in LPS profile and biofilm formation[@R1]--[@R3]. It has recently emerged that a key signal facilitating this decision making process is the universal eubacterial second messenger cyclic-di-GMP (c-di-GMP). The intracellular levels of c-di-GMP are modulated by two classes of enzymes, diguanylate cyclases (DGC), which synthesize c-di-GMP from two molecules of GTP and phosphodiesterases (PDE), which catabolize c-di-GMP to GMP[@R4]--[@R6]. Low levels of c-di-GMP are associated with the early stages of acute infection whereas high levels of c-di-GMP are indicative of chronic infection[@R7]. Another regulatory pathway that has been shown to play a key role in the acute to chronic switch is the Gac/Rsm cascade, where activation of this pathway leads to a sequestration of the master translational regulator RsmA by the small RNAs RsmZ and RsmY. This leads to an increase in the intracellular levels of c-di-GMP and the activation of chronic infection traits such as biofilm formation[@R1],[@R8]. While these two signalling cascades overlap in terms of phenotypic consequence, recent genetic evidence has shown they intersect at a specific membrane bound DGC, SadC. It has been established that SadC is solely responsible for the increased levels of c-di-GMP observed in a *P. aeruginosa* strain that has the Gac/Rsm cascade constitutively activated[@R9]. It has also been shown that RsmA can impact the intracellular levels of SadC most likely at the posttranscriptional level[@R9].

A gap currently exists in the understanding of c-di-GMP as a signalling molecule since for the vast array of phenotypes that are impacted by c-di-GMP levels, comparatively few proteins have been identified that can interact with this dinucleotide. Given that SadC plays a pivotal role in the acute to chronic behavioural change, a bacterial two hybrid screen was performed to identify interacting partners of SadC which play a role in mediating this transition[@R10]. The screen identified a number of candidates, some associated with phenotypes such as motility, however one hit was identified repeatedly. The protein, PA4379, is a predicted methyltransferase with no known phenotypic association. In this study we demonstrate that PA4379 directly interacts with SadC and together they modify the LPS O antigen modal distribution of *P. aeruginosa*. Because of striking homologies with WbdD from *Escherichia coli*, we called the enzyme [War]{.ul}A for [W]{.ul}bdD-like O [A]{.ul}ntigen [R]{.ul}egulator. We also elucidate the molecular mechanism underpinning this LPS phenotype by demonstrating that WarA can bind to c-di-GMP and that this binding influences its enzymatic activity. Finally, we explore the biological significance of the regulation of the LPS O antigen by SadC/WarA on immune evasion using a zebrafish (*Danio rerio*) model of *P. aeruginosa* infection.

SadC interacts with the methyltransferase WarA {#S1}
==============================================

The Gac/Rsm regulatory cascade and c-di-GMP signalling have been established as the key pathways governing the switch from acute to chronic infection phenotypes in *P. aeruginosa*[@R1]. The molecular basis underpinning the link between the Gac/Rsm network and c-di-GMP has been shown to be the membrane associated DGC, SadC[@R9]. Despite the identification of numerous phenotypes influenced by the levels of c-di-GMP within the cell, the mechanisms through which c-di-GMP exerts its phenotypic influence have yet to be fully elucidated. This is largely due to the disparity between the number of enzymes capable of influencing the levels of c-di-GMP within the cell and relatively few proteins that have been shown to interact with c-di-GMP[@R7]. To identify the protein-protein interaction network surrounding the central switch component SadC, a *P. aeruginosa* bacterial two-hybrid (BTH) library was tested[@R10] against *sadC* cloned in the bait vector pKT25 ([Table 1](#T1){ref-type="table"}). One of the SadC partners identified multiple times throughout this screen was the predicted methyltransferase PA4379 we called WarA. The *warA* coding sequence was subsequently amplified from genomic DNA, cloned into pUT18c and re-tested against the *sadC*-encoding BTH vector, which confirmed that the interaction is significant ([Fig. 1a](#F1){ref-type="fig"}). Far western dot blotting[@R11] using purified proteins was utilized to demonstrate that the cytoplasmic domain of SadC which contains the catalytic GGDEF domain is capable of mediating the interaction with WarA ([Fig. 1b](#F1){ref-type="fig"}).

Interestingly the corresponding genomic neighbour of WarA, PA4378, encoding a predicted kinase we called WarB, was also identified in the BTH library screen, although the interaction was significantly weaker than that of WarA ([Sup. Fig. 1](#SD1){ref-type="supplementary-material"}). This prompted investigation into whether WarA and WarB could interact. This was demonstrated initially using a BTH approach ([Fig. 1a](#F1){ref-type="fig"}) and biochemically using far western dot blot analysis ([Fig. 1c](#F1){ref-type="fig"}).

WarAB homolog to the LPS biosynthesis enzyme, WbdD {#S2}
==================================================

*In silico* analysis of genes encoding WarA and WarB showed that they were largely conserved in this genomic arrangement throughout the *Pseudomonas* genus. This high level of synteny, along with the previously described biochemical data, suggests they may function together. To provide additional insight, homology searches were performed using Phyre 2.0[@R12].This analysis not only demonstrated the homology of WarA and WarB to known methyltransferases and kinases, respectively, but when both amino acid sequences were combined a predicted three-dimensional model was generated with a very high confidence on the *E. coli* O9a WbdD protein (19% sequence identity, 69% sequence coverage, 100% confidence) ([Fig. 2a](#F2){ref-type="fig"}, [Sup. Fig. 2](#SD1){ref-type="supplementary-material"}). WbdD has been shown to play a key role in LPS biogenesis in *E. coli* O9a, adding a phosphate and a methyl residue to the terminal-reducing end of the polysaccharide chain, which terminates O antigen synthesis and primes for export across the inner membrane[@R13] ([Fig. 2b](#F2){ref-type="fig"}). A WbdD homolog has not been identified in *P. aeruginosa* although compositional analysis has identified methyl residues on different *P. aeruginosa* LPS species[@R14],[@R15]. Orphan methyltransferases have also been identified that influence the modal distribution but are not associated with a specific kinase[@R16]. *E. coli* O9a is the only currently identified serotype with dual methyltransferase and kinase activity, as in *E. coli* O8 WbdD lacks the kinase domain and functions only as a methyltransferase[@R17],[@R18]. This *in silico* observation prompted further analysis into the potential role of SadC/WarA in LPS synthesis and assembly in *P. aeruginosa*.

WarA has a role in LPS O antigen biogenesis {#S3}
===========================================

*P. aeruginosa* is capable of producing two different glycoforms of LPS *via* two different systems, a heteropolymeric O antigen composed of up to five different polysaccharides termed O-specific antigen (OSA) assembled by a polymerase/flippase-dependent (Wzy/Wzx-dependent) pathway ([Fig. 3a](#F3){ref-type="fig"}) and a homopolysaccharide O antigen composed of repeating rhamnose residues called the common polysaccharide antigen (CPA) produced by an ABC transporter-dependent pathway[@R19],[@R20] ([Fig. 3b](#F3){ref-type="fig"}). To assess if WarA plays a role in LPS biogenesis, a deletion mutant of *warA* was generated in a *P. aeruginosa* PAK background. Preliminary analysis of the LPS profile of a *warA* mutant using silver-stained SDS page gel did not reveal discernable differences ([Sup. Fig. 3](#SD1){ref-type="supplementary-material"}). To achieve greater resolution between the two different LPS glycoforms, antibodies specific to *P. aeruginosa* PAK CPA and OSA were used in western blot analysis. Deletion of *warA* had no significant impact on the modal distribution of OSA ([Fig. 3c](#F3){ref-type="fig"}) but disrupted the CPA modal distribution when compared to wild-type *P. aeruginosa* PAK, as did overexpression of *warA* ([Fig. 3d](#F3){ref-type="fig"}). Remarkably, deletion of *warA* leads to an increase in average chain length of the LPS indicating a loss of regulation in the termination process, while overexpression results in dysregulation and the production of shorter O antigen chains suggesting premature termination of synthesis. This evidence suggests WarA might play a similar functional role as WbdD in regulating chain length and termination of LPS O antigen synthesis.

A key feature of WbdD in *E. coli* O9a is an ability to recruit a specific glycosyltransferase, WbdA to the O antigen assembly interface[@R21]--[@R23]. Three glycosyltransferases encoded within the central *P. aeruginosa* CPA biosynthesis operon, WbpX, WbpY and WbpZ, are homologous to the *E. coli* glycosyltransferases WbdA, WbdB and WbdC, respectively[@R24]. All three glycosyltransferases have been shown to be necessary for CPA biosynthesis[@R24]--[@R26]. Given that deletion of *warA* is capable of impacting CPA modal distribution, it was assessed whether WarA was capable of interacting with any of the primary glycosyltransferases associated with CPA synthesis. Targeted BTH analysis demonstrated that, like WbdD, WarA interacts specifically with the WbdA homolog, WbpX ([Fig. 4a](#F4){ref-type="fig"}). This provides a further link for WarA to CPA biosynthesis and demonstrates consistency in the interactome homology with WbdD.

WarA is a c-di-GMP-binding methyltransferase {#S4}
============================================

Given that WarA was identified as a SadC interacting partner, we hypothesised that WarA and SadC may function in the same regulatory pathway. In agreement with this statement, deletion of *sadC* produced an identical impact on the CPA modal distribution as the deletion of *warA* ([Fig. 3d](#F3){ref-type="fig"}), suggesting that both proteins function together and fine-tune LPS biosynthesis. However, the relevance and molecular consequence of the interaction between SadC and WarA in the process remained to be resolved. This led us to postulate that WarA can bind c-di-GMP. To test this, purified WarA~His~ was used with ^32^P-c-di-GMP to perform a differential radial capillary action of ligand assay (DRaCALA)[@R27]. WarA was capable of binding to c-di-GMP ([Fig. 4b](#F4){ref-type="fig"}) in the low micromolar range, which is consistent with known biologically relevant c-di-GMP binding concentrations ([Sup. Fig. 4a](#SD1){ref-type="supplementary-material"})[@R27],[@R28]. While no c-di-GMP binding motif was obvious from the primary amino acid sequence of WarA, an inverted I-site motif was identified (DDRR)[@R29]. Mutation of the residues in this motif led to a significant drop in c-di-GMP binding affinity suggesting that these residues may play a role in c-di-GMP binding([Sup. Fig. 4b,c](#SD1){ref-type="supplementary-material"}), however binding was not completely abolished suggesting other residues may also be involved. Futher analysis is necessary to conclusively demonstrate the role of this inverted I-site motif in c-di-GMP binding. To test the specificity of binding, competitive DRaCALA assays with unlabelled c-di-GMP and other nucleotides were performed. In all experiments WarA/c-di-GMP binding detection was only shifted by the addition of unlabelled c-di-GMP and by none of the other nucleotides used, including GTP or c-di-AMP ([Fig. 4b](#F4){ref-type="fig"}).

Given the emergent trend of c-di-GMP binding influencing the enzymatic activity of an enzyme[@R28], we hypothesized that binding of c-di-GMP to WarA was capable of influencing its enzymatic activity. Using a fluorescent-based methyltransferase activity assay, LPS was shown to be a substrate for WarA and that increasing the concentration of LPS leads to consequential increase in enzyme activity ([Fig. 4c](#F4){ref-type="fig"}). To test if WarA enzymatic activity was modulated by c-di-GMP binding, c-di-GMP was added across a range of different enzyme concentrations. At every WarA concentration tested, the addition of c-di-GMP led to an increase in the enzymatic activity of WarA ([Fig. 4d](#F4){ref-type="fig"}). This suggests that c-di-GMP is capable of functioning as an agonist, potentiating the enzymatic activity of WarA upon binding. The above-described specific interaction of WarA with SadC suggests that under these circumstances, the spatio-temporal concentrations of c-di-GMP could be high enough to significantly impact WarA activity.

Role of WarA in infection and immune evasion {#S5}
============================================

Numerous studies have demonstrated the physiological relevance of LPS O antigen in *P. aeruginosa* infections. A shift in the LPS profile is commonly observed in chronic *P. aeruginosa* isolates and is recognised as playing a key role in the ability to evade host detection and establish chronic infection[@R30]--[@R33]. To test if the impact of WarA on LPS biogenesis was enough to alter infection progression, two different animal models of infection were utilized, *Galleria mellonella* and the zebrafish (*Danio rerio*)[@R34]--[@R36]. In a *Galleria mellonella* model of infection, a *warA* mutant displays attenuated pathogenicity when compared to the wild type strain. A similar attenuation in pathogenicity was observed with a *sadC* deletion mutant thus supporting the link between these components ([Sup. Fig. 5a](#SD1){ref-type="supplementary-material"}). LPS is one of the primary pathogen associated molecular patterns (PAMPS) that is capable of triggering the host innate immune response and is known to directly stimulate the production of pro-inflammatory cytokines. To visualize *P. aeruginosa* interactions with innate immune cells, *Galleria* were inoculated with GFP-tagged *P. aeruginosa* strains and the hemolymph, the invertebrate equivalent to blood, was exsanguinated 16 hours post infection (hpi). Analysis by fluorescent microscopy suggested that more hemocytes, a primitive arthropod immune cell, were in direct contact with both *sadC* and *warA* mutant bacterial cells as compared to the wild type levels of hemocyte contact. This observation implied that potentially both mutants were more recognisable to the arthropod innate immune system ([Sup. Fig. 5b](#SD1){ref-type="supplementary-material"}).

To investigate the vertebrate innate immune response to *P. aeruginosa*, a *Pseudomonas*- zebrafish hindbrain infection model was developed[@R34],[@R36]. Following injection into the hindbrain ventricle, zebrafish larvae showed *P. aeruginosa* PAK dose-dependent mortality ([Sup. Fig. 6](#SD1){ref-type="supplementary-material"}). In agreement with the *Galleria* survival assays, significantly higher mortality rates were observed in zebrafish larvae infected with the wild type strains as compared to either mutant strain ([Fig. 5a](#F5){ref-type="fig"}). Deletion of *warA* or *sadC* did not reduce bacterial load ([Sup. Fig. 7](#SD1){ref-type="supplementary-material"}) suggesting that an altered immune response (and not bacterial replication) is responsible for host susceptibility to *P. aeruginosa* infection. To directly visualize the innate immune response, we infected Tg(*lyz:*dsRed)*^nz^*[@R50] zebrafish larvae, a transgenic line in which dsRed is expressed specifically in neutrophils[@R37], with GFP-tagged *P. aeruginosa* strains and recorded neutrophil behavior using fluorescent microscopy ([Fig. 5c](#F5){ref-type="fig"}). Strikingly, a more robust neutrophil response is observed during *sadC* mutant infections with more neutrophils recruited to the site of infection as compared to larvae infected with wild type or complemented bacteria ([Fig. 5b,c](#F5){ref-type="fig"}) ([Sup. Vid.1](#SD2){ref-type="supplementary-material"}-[3](#SD4){ref-type="supplementary-material"}, [Sup. Fig. 8a](#SD1){ref-type="supplementary-material"}). This phenotype of significantly increased neutrophil recruitment was also observed for a *warA* deletion mutant, further supporting the link between these two components. In agreement with our results from the *Galleria* model, our *Pseudomonas*-zebrafish infection model confirmed that both *sadC* and a *warA* mutant are more recognisable to host immune cells than wild type bacteria.

The increased neutrophil recruitment response in both mutants suggests that the shift in the LPS modal distribution can impact the ability of the pathogen to establish infection, and implicated the SadC/WarA complex in regulating how *P. aeruginosa* is perceived by the host immune system. To explore this altered immune response, and test if it is due to the altered LPS profile displayed by both mutants, RNA was isolated from zebrafish larvae 6 hpi. This analysis revealed that the *sadC* mutant significantly induced the expression of the LPS associated pro-inflammatory cytokine TNF*-α* to levels higher than those observed in a wild-type or complemented infected host ([Fig. 5d](#F5){ref-type="fig"}). Infection with a *warA* mutant also induced TNF*-α* mRNA levels significantly higher than wild type infected larvae ([Sup. Fig. 8b](#SD1){ref-type="supplementary-material"}). These data strongly suggest that the regulation of LPS by SadC and WarA plays a critical role in immune cell evasion during infection.

Discussion {#S6}
==========

The discovery of c-di-GMP as a second messenger molecule was based on key data that eluciated its ability to bind to a specific cellulose synthase and modulate its activity[@R38],[@R39]. This interaction with c-di-GMP was shown to occur at a binding interface termed the PilZ domain and until recently it was believed to be one of the only c-di-GMP binding domains outside of those directly associated with a diguanylate cyclase domain[@R40]. Recently however, an increasingly diverse array of proteins have been identified that are capable of interacting with nucleotide based second messengers to such an extent that *in silico* prediction of nucleotide binding sites is no longer feasible[@R28],[@R41]--[@R43]. The advancement in our understanding of which proteins can bind c-di-GMP and the molecular consequence of this binding is shedding further light on the complexity of c-di-GMP signalling and confirming the long held hypothesis that spatio-temperal fluctuations in the concentrations of this second messenger can have a localized molecular and kinetic impact[@R7],[@R44].

In this study we identified WarA, as a previously unidentified interacting partner of the DGC SadC, an enzyme previously shown to play a central role in the switch from acute to chronic infection phenotypes[@R1],[@R9]. WarA was shown to specifically interact with the cytoplasmic part of SadC and form a complex with WarB encoded by a convergently transcribed gene. These two proteins in complex had a striking degree of structural homology to the *E. coli* O9a LPS O antigen regulator WbdD[@R13]. Upon further investigation it was demonstrated that they also maintain a degree of functional homology with WbdD, in that loss or overexpression of WarA had impact on CPA O antigen modal distribution. Intriguingly, the deletion of *sadC* had an identical impact on CPA O antigen modal distribution as loss of *warA* suggesting that the interaction of SadC and WarA may be linked in the regulation of LPS biogenesis. Many of the components necessary for CPA O antigen biosynthesis in *P. aeruginosa* are conserved in *E. coli* but no WbdD homolog has been identified leaving the question open as to how CPA O antigen biosynthesis is terminated? Based on structural homology, functional analysis and interactome homology it is likely that WarA is performing a similar function to *E. coli* O9a WbdD ([Fig. 6](#F6){ref-type="fig"}). *E.coli* O9a WbdD has been shown to be the key enzyme signalling the end of O antigen synthesis and priming the O antigen for export across the inner membrane. WarA appears to have lost some of this functionality as the LPS O antigen is still synthesized in the absence of WarA, albeit at a different average chain length. This is not surprising however, as even within *E. coli* species the precise nature and level of regulation of LPS length and export priming exhibited by WbdD can vary and little is known about the functionality of WbdD homologs outside *E. coli*[@R18].

C-di-GMP is known to promote a wide variety of chronic infection features such as biofilm formation[@R1],[@R9]. One specific chronic infection phenotype that has not been previously linked to c-di-GMP levels however, is LPS O antigen biosynthesis. Chronic *P. aeruginosa* isolates from the CF lung are known to display an altered LPS profile. This altered LPS profile is believed to play a role in allowing these isolates to subvert detection by the host immune system and establish chronic infection, however the molecular mechanisms underpinning this LPS profile shift have not been elucidated and have previously been thought to be exclusively the result of genetic mutation[@R2],[@R45]. Given the proximal localization of WarA/SadC with the LPS machinery and the impact of c-di-GMP levels on the activity of WarA ([Fig 6](#F6){ref-type="fig"}), it is plausible that WarA and its enzyme kinetics are playing a key role in modifying the LPS profile of *P. aeruginosa* to better subvert the host innate immune response. We provide evidence using both *Galleria* and zebrafish models of infection which suggests this is indeed the case.

Our study has established another layer in the intricate network of physiological impacts mediated by c-di-GMP at the host-pathogen interface, whereby the levels of c-di-GMP can modulate the activity of an enzyme involved in the synthesis of the key PAMP, LPS. The extent of this impact is mediated at the protein-protein level through the interaction of SadC with WarA, likely recruiting WarA to the membrane, and at the kinetic level by the impact of c-di-GMP binding on the enzymatic activity of WarA. The biological consequence of loss of either of these components is highly impacting the success of the infection notably as observed by a perturbation in the ability to avoid neutrophil recruitment and to escape the innate immune response.

Materials & Methods {#S7}
===================

Bacterial Strains {#S8}
-----------------

Primers used in this study are listed in [Supplementary Data Table 1](#SD1){ref-type="supplementary-material"}, while bacterial strains and plasmids used in this study are listed in [Supplementary Data Table 2](#SD1){ref-type="supplementary-material"}. Cells were grown in Lysogeny Broth (LB) [@R46],[@R47] in 100 ml Erlenmeyer flasks filled with 20 ml of medium, with shaking at 180 rpm and at 37°C. LB agar (NA) was used as a solid medium. When required, antibiotics were added to these media at the following concentrations: 100 μg/ml ampicillin, and 10 μg/ml gentamicin for *E. coli*; and 300 μg/ml carbenicillin, 50 μg/ml gentamicin and 125 μg/ml tetracycline, 2000 μg/ml streptomycin for *P. aeruginosa*.

Cloning procedures {#S9}
------------------

DNA cloning and plasmid preparation were performed according to standard methods [@R48]. PCR primers were designed with restriction sites at their ends for subsequent digestion and ligation into the specific vector. Restriction and DNA-modifying enzymes were used following the instructions of the manufacturers. Transformation of *E. coli* DH5α, *E. coli* TOP10 (for cloning) and *P. aeruginosa* was carried out by electroporation[@R49]. All plasmids were verified by sequencing. All mutations were confirmed by DNA sequencing. The background strains were tagged with GFP by means of four-parental mating with *E. coli* harbouring pBK-miniTn7-ΩGm as donor strains and with *E. coli* strains harbouring pUX-BF13 and pRK2013 as helper strains.

Gene Replacement Mutants {#S10}
------------------------

For the deletion of the PA4379 (*warA*) gene in the *P. aeruginosa* PAK chromosome previously described protocol was followed. Briefly, a fragment containing the upstream region and the first 2 codons of PA4379 and a fragment downstream containing the PA4379 stop codon were amplified by PCR using the primer pairs pPA4379.1/ pPA4379.2 and pPA4379.3/ pPA4379.4, respectively. Mutator fragments were constructed by PCR amplification of upstream and downstream fragments using the primer couple p PA4379.1/p PA4379.4 and cloned into pCR2.1-BLUNT. The mutator fragment was digested from pCR2.1-Blunt and ligated into pKNG101. This construct was transformed into *E. coli* CC18, was then introduced into *P. aeruginosa* PAK by triparental mating, using the helper strain *E.coli* HB101 (pRK2013). Transconjugants were isolated on Pseudomonas Isolation Agar (Difco) supplemented with appropriate antibiotics. Deletion mutants were selected in 5% sucrose after 2 days of incubation at room temperature. Deletions were confirmed by sequencing using external primers pPA4379.5/ pPA4379.6. The resulting strain PAKΔ*warA*, carried an in-frame ΔPA4379 mutation. Overexpression constructs were generated using the primer combinations p pPA4379OeF/pPA4379OeF and cloned into the isopropyl β-d-thiogalactoside (IPTG) inducible vector pMMB67HE. The mutated WarA construct was generated using the primer combination pWarAMutF/pWarAMutR.

β-Galactosidase assays {#S11}
----------------------

β-Galactosidase experiments were performed as described previously [@R47], with *E. coli* cells harvested from agar plates and resuspended in PBS . Data are mean values of three independent samples ± standard deviations.

Expression and Protein Purification {#S12}
-----------------------------------

The *warA* (PA4379),*warB* (PA4378) and *sadC* genes and were amplified from *P. aeruginosa* PAK genomic DNA using the following primer combinations pWarAF.1/pWarAF.2, pWarBF.1/pWarBF.2,pSadCCDH.1/pSadCCDH.2 and cloned into pET28a with SadC CD and WarA having an N terminal His Tag and WarB having a C terminal His tag. For GST tagging of WarA and WarB the following primer combinations were used pWarAGST.1/pWarAGST.2 and pWarBGST.1/pWarBGST.2 and cloned into pET-41a-3CD, a vector derived from pET-41a by Novagen to produce fusion proteins with N-terminal GST-His-S tag. In all cases, transformed *E.* *coli* B834(DE3) cells were grown at 37 °C to an OD~600~ of about 0.6 in Tryptic Soy broth. Expression of proteins was induced with 0.5 mM IPTG, and cells were grown overnight at 18 °C before centrifugation (4,000 × *g*, 20 min at 4 °C). Cell pellets were resuspended in buffer A (50 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole (pH 8.0)) and lysed by sonication after the addition of an anti-protease mixture (Sigma). Cell debris was eliminated by centrifugation (18,000 × *g*, 50 min).

Proteins were purified by IMAC chromatography using nickel-Sepharose resin (GE Healthcare) equilibrated in buffer A. Proteins were eluted with buffer A containing 500 mM instead of 20 mM imidazole and if necessary were further purified by size exclusion chromatography using a HiLoad Superdex 75 column equilibrated in 50 mM Tris-HCl and 250 mM NaCl (pH 8). All chromatographic steps were performed on an ÄKTAprime Plus system (GE Healthcare) at 4 °C. Protein purity was checked by SDS-PAGE. Proteins were dialyzed overnight in a low sodium buffer (250 mM) with no added imidazole and concentrated using centrifugal concentrators (Millipore) and stored at −80 °C.

[D]{.ul}ifferential [Ra]{.ul}dial [C]{.ul}apillary [A]{.ul}ction of [L]{.ul}igand [A]{.ul}ssay (DRaCALA) {#S13}
--------------------------------------------------------------------------------------------------------

This assay is based on the ability of nitrocellulose to separate free ligand from bound protein-ligand complexes, allowing the determination of a protein ligand interaction. DRaCALA assays were performed as described by Roelofs et al. [@R27]. Briefly, ^32^P-labelled c-di-GMP is generated from \[α-^32^P\]-GTP using purified WspR. Purified WarA~His~ in binding buffer was mixed with 4nM ^32^P-labeled c-di-GMP. 100 μM of unlabelled nucleotides was added to the reaction mixture containing 50 μM WarA in the cold competition experiments. These mixtures were pipetted (2.5 μl) onto dry untreated nitrocellulose (GE Healthcare) in triplicate and allowed to dry for ten minutes. An FLA7100 Fujifilm Life Science PhosphorImager was used to detect luminescence following a 10-min exposure of blotted nitrocellulose to phosphorimager film. Data were quantified using ImageQuant TL Toolbox v8.1. Nonlinear regression analysis determined binding Kd using the saturation binding equation Y = Bmax\*X/(Kd + X) as described by Roelofs *et al.,* 2011. Data shown are one representative experiment of three independent experiments.

Bacterial two-hybrid assay {#S14}
--------------------------

Bacterial two hybrid experiments and cloning strategies were performed as previously described[@R10],[@R50],[@R51]. DNA fragments encoding proteins of interest were cloned into pKT25 and PUT18c. DNA regions encoding WarA, WarB, SadC CT, WbpX, WbpY and WbpZ were amplified by using the following primer combinations pSadCCD.1/pSadCCD.2 pPA4378.1/pPA4378.2, pSadCFL.1/pSadCFL.2, pPA4379B2H.1/ pPA4379B2H.2, pWbpY.1/pWbpY.2, pWbpX.1/pWbpX.2, pWbpZ.1/pWbpZ.2. Recombinant pKT25 and pUT18C plasmids were transformed simultaneously into the *E. coli* DHM1 strain and transformants were spotted onto LB agar plates supplemented with 1mM IPTG in the presence of 100 μg/ml ampicillin, 50 μg/ml kanamycin, and 100 μg/ml 5-bromo-4-chloro-indolyl-β-d-galactopyranoside (X-gal). Positive interactions were identified as blue colonies after 24h incubation at 30°C and quantified by β-galactosidase assays. The positive controls used in the study were pUT18C and pKT25 derivatives encoding the leucine zipper from GCN4, which strongly dimerizes (zip).

LPS Analysis {#S15}
------------

LPS was prepared as described by Hitchcock and Brown (1983) and visualized on 12% SDS-Page gels using the ultrafast silver staining method [@R52]. For LPS Western Immunoblotting, LPS was transferred onto BioTraceNT nitrocellulose membranes (Pall), and probed using monoclonal antibody (MAb) N1F10 (CPA specific), and MAb MF15-4 (OSA specific). The secondary antibody used was alkaline phosphatase-conjugated goat anti-mouse Fab~2~ (Jackson ImmunoResearch), and the blots were developed using nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP) as described previously [@R53],[@R54]. For further LPS purification, total membranes were isolated. In brief, bacterial cells were collected by centrifugation and suspended in 1ml 50 mM Tris pH 8.0 supplemented with complete® protease inhibitor cocktail (Roche) and 1mM EDTA Cells were lysed by sonication. Intact cells were removed by centrifugation 4000 x g for 5 mins at 4 °C, taking uppermost supernatant each time. Soluble and membrane fractions were separated by centrifugation at 100,000g for 1h at 4 °C. Pellet was taken as total membrane and further treated as described by Hitchcock and Brown (1983).

Far Western Dot Blots {#S16}
---------------------

Far Western Blots were performed as described in [@R11]. In brief, purified His tagged WarA, SadC Cytoplasmic Domain and WspR were spotted onto a nitrocellulose membrane (GE Healthcare) at comparable concentrations. The spots were let dry before the membrane was blocked with 5% milk in PBST (4 mM KH~2~PO~4~, 16 mM Na~2~HPO~4~, 115 mM NaCl (pH 7.4) and 0.05% Tween-20) for 1h at room temperature and then incubated overnight at 4C in Protein-binding buffer (100 mM NaCl, 20 mM Tris (pH 7.6), 0.5 mM EDTA, 10% glycerol, 0.1% Tween-20, 2% skim milk powder and 1 mM DTT) with 15 μg of purified GST tagged WarA or WarB. The following day, the membrane was washed three times with TBST to wash off unbound WarA~GST~ /WarB~GST~. Membrane-bound WarA~GST~/WarB~GST~ was detected by using monoclonal anti-GST antibody (GE Healthcare) at a dilution 1:1000. Secondary antibody conjugated to horseradish peroxidase was used at a dilution of 1:5000. Western blots were developed using Super-Signal West Pico Chemiluminescent Substrate (Pierce) and visualized on a LAS3000 Fuji Imager.

Methyltransferase Activity Assay {#S17}
--------------------------------

Methyltransferase activity assays were performed using a methyltransferase activity kit (Enzo Life Science, Farmingdale, NY) as per manufacturer's specifications using S-adenosyl-L-methionine as the methyl group donor and measuring activity in relative fluorescent units. Assays were performed using Ni-NTA affinity column purified WarA that had been dialysed in a low sodium buffer to remove imidazole. This low sodium buffer was also used to resuspended lyophilized c-di-GMP (BioLog) and further purified LPS from a Δ*warA* mutant. Data shown are one representative experiment of three independent experiments.

Galleria Assay {#S18}
--------------

The wax moth model *Galleria mellonella* was used for *in vivo* pathogenicity assessment. Overnight cultures were diluted 1:100 and subcultured (10ml LB/ 50ml conical flask) at 37°C until early exponential phase. Bacterial cells (OD600= 0.7-0.8) are centrifuged (8,000 rpm, 4°C, 5min) and resuspended to PBS three times to a final concentration OD600=1. The samples were serially diluted (up to 10^−8^).10μl of the 10^--6^ dilution were injected into the last abdominal proleg of ten larvae per sample; additional ten larvae were injected with PBS as negative control. 20μl of the dilutions were spotted and enumerated the next day. The larvae mortality was monitored for 48h on an hourly basis (Note: dead larvae turn black due to melanisation and do not respond to tapping). Three biological replicates were produced. For fluorescent microscopy Harding *et al*,[@R55] was followed with *Galleria* being inoculated with PAK::*gfp*, PAKΔ*warA*::*gfp* and PAKΔ*sadC*::*gfp* and exsanguinated 16 hours post infection.

Ethics statement {#S19}
----------------

Animal experiments were performed according to the Animals (Scientific Procedures) Act 1986, and were fully approved by the Home Office (Project license: PPL 70/7446). Animal experiments performed at Imperial College were performed according to the Animals (Scientific Procedures) Act 1986, and were fully approved by the Home Office (Project license: PPL 70/7446). All experimentation involving zebrafish have been performed in larvae up to 5 days post fertilization (ie what is legally considered as in vitro experimentation). To minimize the effects of subjective bias some experiments were performed by different lab members.

Zebrafish care and maintenance {#S20}
------------------------------

Wild type AB purchased from the Zebrafish International Resource Center (Eugene, OR) and the Tg(*lyz:*dsRed)^*nz50*^ transgenic zebrafish line have been previously described [@R37]. Eggs were obtained by placing egg collection baskets inside the breeding tanks, bleached according to protocols described in [@R56], and then kept in Petri dishes containing E2 water supplemented with 0.3μg/ml of methylene blue and from 24hpf onwards for microscopy purposes with 0.003% 1-phenyl-2-thiourea (Sigma-Aldrich) to prevent melanization.

Zebrafish bacterial infection {#S21}
-----------------------------

Hindbrain infections were performed as described by Rocker *et al.,*[@R57] Bacterial strains used in this study were PAK::*gfp*, PAKΔ*sadC*::*gfp* and PAKΔ*warA*::*gfp*. Bacteria were cultured overnight in TSB, diluted to an A~600nm~ 0.01 and cultured until A~600nm~ = 0.7. For injection of zebrafish larvae, bacteria were recovered by centrifugation, washed and reconstituted at the desired concentration in 1x PBS 0.1% phenol red. 3dpf anesthetized zebrafish larvae were microinjected in the hindbrain ventricle with 1-2nl of bacterial suspension.

Quantification of bacterial burden {#S22}
----------------------------------

At the indicated times, larvae were sacrificed in tricaine, lysed in 200μl of 0.4% Triton X-100 and homogenized mechanically[@R58]. Larval homogenates were serially diluted and plated on LB: Gm50 agar and plates were incubated at 37°C. Only larvae having survived the infection were included for CFU enumeration.

Live imaging, image processing and analysis {#S23}
-------------------------------------------

Whole-animal *in vivo* imaging was performed on anaesthetized zebrafish larvae immobilized in 1% low melting point agarose in 60mm Petri dishes covered with E2 containing tricaine as previously described [@R59]. Transmission and fluorescence microscopy was done using a Leica M205FA fluorescent stereomicroscope. Imaging was performed at 28°C with a 10x (NA 0.5) dry objective. Multiple-field Z-stacks were acquired every 15min. AVI files were processed and annotated using ImageJ software. Neutrophils were quantified by defining a consistent area around the site of infection (as defined by white box enlarged in inset image) and counting neutrophils within this area.

qRT-PCR {#S24}
-------

Total RNA from snap-frozen larvae was extracted using RNAqueous Kit (Ambion). cDNA was obtained using QuantiTect reverse transcription kit (Qiagen). Primers used to measure TNF*-α* mRNA levels were from Stockhammer *et al*. [@R60]. Quantitative PCR was performed on a Rotor-GeneQ (Qiagen) using SYBR green reaction power mix (Applied Biosystems). Quantifications were performed on triplicate wells. To normalize cDNA amounts, we used the housekeeping gene *ef1α* [@R58].

Data Availability {#S25}
-----------------

The data that support the findings of this study are available from the corresponding author on reasonable request.
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![WarA interacts with SadC.\
**a,** Bacterial two hybrid assay to validate interaction between WarA and the cytoplasmic domain (CD) of SadC. A graphical representation of β-galactosidase activity from *E. coli* DHM1 cells producing the indicated proteins fused to the adenylate cyclase T25 or T18 subunits. Corresponding spots on LB X-Gal plates are shown. Activity was measured in Miller units. **b,** Purified SadC (CD)~His~ (16 μg) and WspR~His~ (16 μg) spotted on a nitrocellulose membrane probed with purified WarA~HisGST~ overnight. A GST antibody was used to detect binding. **c,** Purified WarA~His~ (10 μg) and WspR~His~ (10 μg) spotted on a nitrocellulose membrane probed with purified WarB~HisGST~ overnight. Standard deviation error bars shown and representative images/data of at least 3 replicates shown. Significance testing performed by Student's t test. \*, P\<0.05; \*\*, P\<0.01.](emss-71401-f001){#F1}

![Structural homology of WbdD and WarAB.\
**a***,* Superposition of WbdD (Magenta) secondary structure (PDB:4AZW) with that of the Phyre 2.0 predicted secondary structure of WarAB (Cyan). S-Adenosyl methionine (SAM) in blue (WarA) and ATP in yellow (WarB). Selected residues highlighted. **b,** Model of LPS O antigen biosynthesis in *E. coli* O9a. The glycosyltransferases WbdA, WbdB and WbdC are responsible for the synthesis of the O antigen. WbdD adds a phosphoryl and a methyl group to the terminal-reducing end of the O antigen, this terminates synthesis and primes the chain for export through the inner membrane via the ABC transporter Wzm/Wzt. Components of model individually labelled with corresponding names.](emss-71401-f002){#F2}

![WarA impact LPS modal distribution.\
**a,** Model of the heteropolymeric OSA biosynthesis via the Wzy/Wzx-dependent pathway. Individual repeating units are assembled in the cytoplasm and transported *via* a flippase across the inner membrane to the periplasmic space. Here they are assembled into the O antigen polymer by the Wzy polymerase. Wzz~1~ and Wzz~2~ regulate chain length. **b,** Model of CPA biosynthesis via the ABC transporter pathway. Like LPS biosynthesis in *E.coli* O9a, synthesis and assembly occur in the cytoplasm via the glycosyltransferases WbpX, WbpY and WbpZ. The assembled O antigen component is then transported via the Wzm/Wzt ABC transporter across the inner membrane. **c,** Western blot analysis using OSA specific antibody MF83-1 on PAK wild type with an empty vector (+ Ev), PAK wild type overexpressing *warA (+ warA*Oe), a *sadC* and a *warA* mutant. **d,** Western blot analysis using CPA specific antibody (N1F10) on PAK wild type with an empty vector (+ Ev), PAK wild type overexpressing *warA (+ warA*Oe), a *sadC* and a *warA* mutant. Representative images of at least two biological replicates shown.](emss-71401-f003){#F3}

![WarA is a functional methyltransferase and binds c-di-GMP.\
**a,** Bacterial two hybrid screen of the interaction between WarA and the glycosyltransferases of the primary CPA biosynthesis cluster WbpX, WbpY and WbpZ. A graphical representation of β-galactosidase activity from *E. coli* DHM1 cells producing the indicated proteins fused to the adenylate cyclase T25 or T18 subunits. Corresponding spots on LB X-Gal plates are shown. Activity was measured in Miller units. **b,** DRaCALA analysis of WarA using increasing concentrations of WarA. Competition experiment (Middle Panel) using unlabelled c-di-GMP (100 μM), various other nucleotides (100μM) were used to test specificity of WarA (50 μM) binding (bottom panel). **c,** A fluorescent-based methyltransferase activity assay was used to determine WarA activity in increasing concentrations of LPS. **d,** Addition of c-di-GMP (15 μM) to the reaction mix at a range of different WarA concentrations. Representative images/data of at least 3 replicates shown. Standard deviation error bars shown. Significance testing performed by Student's t test. \*, P\<0.05; \*\*, P\<0.01; \*\*\*; P\<0.001.](emss-71401-f004){#F4}

![Role of SadC and WarA in infection and immune evasion.\
**a,** Survival analysis of zebrafish 3 days post fertilization (dpf) infected in the hindbrain ventricle with *P. aeruginosa* at a dose of 5 x 10^4^ CFU. Zebrafish challenged with either mutant displayed a reduced mortality at 12 hpi (12 hpi, ANOVA, \*, P\<0.05). Data is representative of at least 3 independent biological replicates with a minimum of at least 24 fish per replicate. **b,** Representative images of *lyz:*dsRed larvae infected in the hindbrain with PAK::*gfp*, PAKΔ*sadC*::*gfp* and PAKΔ*warA*::*gfp* from panel C. For each treatment, the same larva was imaged at 0, 6 and 12 hpi using a fluorescent stereomicroscope, where neutrophils were quantified at the site of infection (as defined by the white box, enlarged as inset image) (See also [Video S1](#SD2){ref-type="supplementary-material"}, [S2](#SD3){ref-type="supplementary-material"} and [S3](#SD4){ref-type="supplementary-material"}).**c,** Neutrophils were counted around the site of infection at 0 and 6 hours hpi for zebrafish larvae infected in the hindbrain ventricle with 5 x 10^4^ CFU of PAK::*gfp*, PAKΔ*sadC::gfp* and PAKΔ*sadC::gfp +*p*sadC*. Data is from 4 independent biological replicates with 3-6 larvae per strain per replicate. Standard deviation error bars are shown. Significance testing performed by Student's t test: \*, P\<0.05; \*\*, P\<0.01. **d,** TNF*-α* mRNA levels in larvae infected with 5 x 10^4^ CFU for 6h. TNF*-α* mRNA are relative to the house keeping gene *ef1α.* Mean ± SEM (horizontal bars) from 3 independent experiments with 5 pooled larvae per strain per experiment. Significance testing performed by Student's t test: \*, P\<0.05; \*\*, P\<0.01.](emss-71401-f005){#F5}

![Role of WarA in CPA biosynthesis.\
SadC recruits WarA to the inner membrane where it interacts with the CPA O antigen machinery by recruiting WbpX to the assembly interface and also by potentiating the methyltransferase activity of WarA. This fine tuning regulation plays a key role in allowing the cell to escape detection by the host innate immune system.](emss-71401-f006){#F6}

###### Selected hits from the bacterial two hybrid screen using SadC as a bait.

WarA was identified in 4 separate prey vectors. Strong hits were categorised as those that displayed a blue colour after 2 days incubation on LB X-gal Km/Amp plates. Weak hits were those that did not develop a blue colour until 4 days of incubation.

  Hit                                                      Comments                    Gene product
  -------------------------------------------------------- --------------------------- --------------------------------------------
  ***Strong interactions (after 2 days of incubation)***                               
                                                                                       
  **FimV (PA3115)**                                        **Hits the N-terminus**     **Motility membrane protein (twitching)**
  **PA3926**                                               **Hits the C-terminus**     **Hypothetical sugar transporter**
  **WarA**                                                 **Hit 4x**                  **Methyltransferase**
  **PA4459**                                                                           **Lipopolysaccharide assembly**
                                                                                       
  ***Weaker interactions (after 4 days of incubation)***                               
                                                                                       
  **PA1378**                                                                           **Hypothetical**
  **PA1891**                                                                           **Membrane protein**
  **PA3403**                                                                           **Phosphate starvation inducible protein**
  **cysE (PA3816)**                                        **Hits the C-terminus**     **O-acetylserine synthase**
  **WarB**                                                 **Same operon as *warA***   **Lipopolysaccharide kinase**
  **PilS (PA4546)**                                        **Hit 2x**                  **Two-component membrane sensor**
  **PA4929**                                               **Hits the C-terminus**     **Diguanylate cyclase**
  **AtpF (PA5558)**                                                                    **ATP synthase B chain**

[^1]: Present address: Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Group of Molecular Microbiology, Instituto de Biologia Molecular e Celular, Porto, Portugal.
